174 related articles for article (PubMed ID: 21219628)
1. Structural and functional characterization of human apolipoprotein E 72-166 peptides in both aqueous and lipid environments.
Hsieh YH; Chou CY
J Biomed Sci; 2011 Jan; 18(1):4. PubMed ID: 21219628
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional variations in human apolipoprotein E3 and E4.
Chou CY; Jen WP; Hsieh YH; Shiao MS; Chang GG
J Biol Chem; 2006 May; 281(19):13333-13344. PubMed ID: 16540478
[TBL] [Abstract][Full Text] [Related]
3. Influence of Isoforms and Carboxyl-Terminal Truncations on the Capacity of Apolipoprotein E To Associate with and Activate Phospholipid Transfer Protein.
Dafnis I; Metso J; Zannis VI; Jauhiainen M; Chroni A
Biochemistry; 2015 Sep; 54(38):5856-66. PubMed ID: 26337529
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia in APOE2 transgenic mice is ameliorated by a truncated apoE variant lacking the C-terminal domain.
Gerritsen G; Kypreos KE; van der Zee A; Teusink B; Zannis VI; Havekes LM; van Dijk KW
J Lipid Res; 2003 Feb; 44(2):408-14. PubMed ID: 12576523
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism.
Acharya P; Segall ML; Zaiou M; Morrow J; Weisgraber KH; Phillips MC; Lund-Katz S; Snow J
Biochim Biophys Acta; 2002 Sep; 1584(1):9-19. PubMed ID: 12213488
[TBL] [Abstract][Full Text] [Related]
6. Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.
Nguyen D; Dhanasekaran P; Nickel M; Mizuguchi C; Watanabe M; Saito H; Phillips MC; Lund-Katz S
Biochemistry; 2014 Jun; 53(24):4025-33. PubMed ID: 24871385
[TBL] [Abstract][Full Text] [Related]
7. Lipid binding ability of human apolipoprotein E N-terminal domain isoforms: correlation with protein stability?
Weers PM; Narayanaswami V; Choy N; Luty R; Hicks L; Kay CM; Ryan RO
Biophys Chem; 2003; 100(1-3):481-92. PubMed ID: 12646385
[TBL] [Abstract][Full Text] [Related]
8. Structural variation in human apolipoprotein E3 and E4: secondary structure, tertiary structure, and size distribution.
Chou CY; Lin YL; Huang YC; Sheu SY; Lin TH; Tsay HJ; Chang GG; Shiao MS
Biophys J; 2005 Jan; 88(1):455-66. PubMed ID: 15475580
[TBL] [Abstract][Full Text] [Related]
9. Effects of polymorphism on the lipid interaction of human apolipoprotein E.
Saito H; Dhanasekaran P; Baldwin F; Weisgraber KH; Phillips MC; Lund-Katz S
J Biol Chem; 2003 Oct; 278(42):40723-9. PubMed ID: 12917433
[TBL] [Abstract][Full Text] [Related]
10. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
11. Domains of apoE required for binding to apoE receptor 2 and to phospholipids: implications for the functions of apoE in the brain.
Li X; Kypreos K; Zanni EE; Zannis V
Biochemistry; 2003 Sep; 42(35):10406-17. PubMed ID: 12950167
[TBL] [Abstract][Full Text] [Related]
12. Differences in stability among the human apolipoprotein E isoforms determined by the amino-terminal domain.
Morrow JA; Segall ML; Lund-Katz S; Phillips MC; Knapp M; Rupp B; Weisgraber KH
Biochemistry; 2000 Sep; 39(38):11657-66. PubMed ID: 10995233
[TBL] [Abstract][Full Text] [Related]
13. Structural variation manipulates the differential oxidative susceptibility and conformational stability of apolipoprotein E isoforms.
Su KL; Wen TH; Chou CY; Chang GG; Liu GY; Hung HC
Proteins; 2007 Jul; 68(1):363-74. PubMed ID: 17410580
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the binding of amyloid-beta peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma.
Yang DS; Smith JD; Zhou Z; Gandy SE; Martins RN
J Neurochem; 1997 Feb; 68(2):721-5. PubMed ID: 9003062
[TBL] [Abstract][Full Text] [Related]
15. Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE.
Lund-Katz S; Wehrli S; Zaiou M; Newhouse Y; Weisgraber KH; Phillips MC
J Lipid Res; 2001 Jun; 42(6):894-901. PubMed ID: 11369796
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E4 forms a molten globule. A potential basis for its association with disease.
Morrow JA; Hatters DM; Lu B; Hochtl P; Oberg KA; Rupp B; Weisgraber KH
J Biol Chem; 2002 Dec; 277(52):50380-5. PubMed ID: 12393895
[TBL] [Abstract][Full Text] [Related]
17. Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles.
Garai K; Baban B; Frieden C
Biochemistry; 2011 Apr; 50(13):2550-8. PubMed ID: 21322570
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E structural requirements for the formation of SDS-stable complexes with beta-amyloid-(1-40): the role of salt bridges.
Bentley NM; Ladu MJ; Rajan C; Getz GS; Reardon CA
Biochem J; 2002 Aug; 366(Pt 1):273-9. PubMed ID: 12015813
[TBL] [Abstract][Full Text] [Related]
19. The receptor binding domain of apolipoprotein E is responsible for its antioxidant activity.
Pham T; Kodvawala A; Hui DY
Biochemistry; 2005 May; 44(20):7577-82. PubMed ID: 15896001
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of apolipoprotein E isoforms overexpressed in Escherichia coli.
Morrow JA; Arnold KS; Weisgraber KH
Protein Expr Purif; 1999 Jul; 16(2):224-30. PubMed ID: 10419818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
